CareDx(us:CDNA)

17.75

-1.17%

Updated on 2025-03-31

Open:17.25
Close:17.75
High:17.87
Low:17.05
Prev Close:17.96
Volume:579576.00
Turnover:10.22M
Turnover Ratio:1.05%
Shares:55.43M
MarketCap:983.81M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3017353412181101.51%324879
2024-03-3116055065186106.34%164876
2023-12-3117553612656104.10%254883
2023-09-3016855839010103.11%175182
2023-06-3017257407105106.28%185677
2023-03-3118357685089107.40%216672
2022-12-3120157864461108.09%226787
2022-09-3020656443944105.46%247381
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Ark Investment Management Llc586404611.32%-1330676-18.50%
2024-03-31Blackrock Inc.542503110.48%-118635-2.14%
2024-03-31Vanguard Group Inc43000168.30%1803344.38%
2024-03-31State Street Corp41963408.10%140007350.07%
2024-03-31Bellevue Group Ag39340067.60%-20786-0.53%
2024-03-31Sumitomo Mitsui Trust Holdings, Inc.27483385.31%-126561-4.40%
2024-03-31Nikko Asset Management Americas, Inc.27483385.31%-126561-4.40%
2024-03-31Gagnon Securities Llc22455294.34%1494857.13%
2024-03-31D. E. Shaw & Co., Inc.20221343.91%-179087-8.14%
2024-03-31Dimensional Fund Advisors Lp14458022.79%40628139.08%

About

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Address:8000 Marina Boulevard

Market Movers